Here's my assessment of your WGBS run:

---

## WGBS Run Summary: Bap1/Math1 Ctrl vs Mut

### Experimental Design
4 samples, paired-end 101bp reads, directional WGBS:
- **Controls:** ctrl_3139, ctrl_3200
- **Mutants:** mut_3201, mut_3391

### The Verdict: The experiment worked, but one sample is severely underpowered.

---

### Alignment & Mapping (Bismark)

| Sample    | Raw Read Pairs | Alignment Rate | Dedup Reads | Dup Rate |
| --------- | -------------- | -------------- | ----------- | -------- |
| ctrl_3139 | 16.8M          | **72.4%**      | 9.1M        | 18.1%    |
| ctrl_3200 | 13.8M          | **70.2%**      | 7.4M        | 16.3%    |
| mut_3201  | **4.3M**       | **70.2%**      | 2.3M        | 15.9%    |
| mut_3391  | 13.6M          | **77.5%**      | 8.3M        | 13.5%    |

- Alignment rates 70-77% are **solid for WGBS** (bisulfite conversion heavily mutates C>T, so 70%+ is expected and good).
- Duplication rates 13-18% are **very reasonable** -- no evidence of library complexity issues.
- **mut_3201 is a major concern** -- only ~4.3M read pairs vs 13-17M for the other three. This sample will be underpowered for DMR calling.

### Genome Coverage (Qualimap)

| Sample    | Mean Coverage | Median Coverage | 1x Coverage |
| --------- | ------------- | --------------- | ----------- |
| ctrl_3139 | 0.65x         | 0x              | 39.9%       |
| ctrl_3200 | 0.53x         | 0x              | 32.4%       |
| mut_3201  | **0.16x**     | 0x              | **11.2%**   |
| mut_3391  | 0.59x         | 0x              | 37.5%       |

This is **very low coverage across the board** -- median coverage is 0x for all samples, meaning most of the genome has no reads. Even the best sample (ctrl_3139) only covers ~40% of the genome at 1x. For robust CpG methylation calls you typically want 5-10x+ at individual CpGs. This level of sequencing depth is compatible with a **pilot/screening run** or **RRBS-like targeted analysis**, but not a genome-wide differential methylation analysis at single-CpG resolution.

### Bisulfite Conversion & Methylation (the key biology check)

| Sample    | CpG meth% | CHG meth% | CHH meth% |
| --------- | --------- | --------- | --------- |
| ctrl_3139 | **81.0%** | 1.2%      | 1.4%      |
| ctrl_3200 | **81.3%** | 0.9%      | 1.1%      |
| mut_3201  | **81.6%** | 1.1%      | 1.3%      |
| mut_3391  | **79.3%** | 1.0%      | 1.2%      |

- **Bisulfite conversion is excellent.** CHG/CHH methylation at ~1% is the gold standard indicator -- non-CpG contexts should be near-zero in somatic tissue, and 1-1.5% is right where you want it.
- **CpG methylation at ~80%** is biologically consistent with mammalian somatic tissue (typically 70-85%).
- These numbers are **highly consistent across all 4 samples**, which means the library prep and BS conversion worked uniformly.

### M-bias (Positional Methylation Bias)

CpG methylation across read positions is flat at ~80% for positions 10-101, with an expected inflation at positions 1-6 (~85-90%). This is the **classic WGBS M-bias profile** -- the first few bases show end-repair artifacts. Standard practice is to ignore the first 5-10 bases in downstream methylation extraction (Bismark's `--ignore` flag). The flat profile across the rest of the read confirms **no systematic bias**.

### FastQC

The FastQC "fails" are all **expected for bisulfite data** and not real problems:
- **Per Base Sequence Content: FAIL** -- expected, bisulfite conversion destroys C>T balance
- **Per Sequence GC Content: FAIL** -- expected, GC shifts due to C>T conversion
- **Per Tile Sequence Quality: FAIL** -- some tile-level variation (common, minor)
- **Overrepresented Sequences: FAIL** -- likely adapter dimers/bisulfite artifacts
- **Adapter Content: FAIL** -- adapters trimmed by Cutadapt (11-17% trimmed, normal range)
- **Base quality: PASS** across all samples -- the actual sequence quality is good

### Trimming (Cutadapt)

11-17% of bases trimmed, which is normal for WGBS libraries. No samples showed excessive trimming.

---

## Bottom Line

**The experiment technically worked** -- the biochemistry (BS conversion, library prep, sequencing quality) is all solid. But:

1. **mut_3201 needs to be resequenced or excluded.** At 4.3M reads and 0.16x coverage, it's ~3-4x lower than the other samples. This will cripple any statistical comparison.

2. **Overall coverage is very low for genome-wide WGBS.** At 0.5-0.65x mean coverage, you're covering 30-40% of the genome at 1x. For whole-genome DMP/DMR analysis, you'd typically want 10-30x. If this was intended as a pilot to verify the library prep worked before deeper sequencing -- it succeeded. If this was intended as the production run, you'll need significantly more sequencing.

3. **If working with what you have**, consider: focusing on well-covered regions only, pooling CpGs into larger windows (e.g., 1kb tiles), or using tools designed for low-coverage BS-seq (like MethylDackel with minimum coverage filters + BSmooth for smoothing).

Would you like me to dig deeper into any particular aspect, or help set up the downstream analysis pipeline?